Positive clinical trial results for olaparib in advanced prostate cancer 07 Aug 2019 The preliminary results of a major phase III clinical trial show that the genetically targeted drug olaparib improves outcomes for men with advanced prostate cancer whose tumours have DNA repair faults. Find out more Show/Hide
Gene test picks out prostate cancers patients who could benefit from ‘search-and-destroy’ medicine 23 Jul 2019 Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted nuclear medicine, a new study reports. Find out more Show/Hide
ASCO 2019: Breast cancer drug effective in 80 per cent of men with BRCA-mutant prostate cancer 05 Jun 2019 A pioneering gene-targeted drug already licensed for breast and ovarian cancer can benefit some men with prostate cancer, a major new clinical trial reports. Find out more Show/Hide
Protein found more in advanced prostate cancer could be key to preventing drug resistance 08 Jan 2019
Call for hospitals to use high-tech scans to diagnose prostate cancers when they can still be cured 17 Nov 2018
ESMO 2018: Cancer trial shows treating the prostate directly with radiotherapy improves survival 22 Oct 2018